Synageva Biopharma (GEVA) Posts Q4 Loss of 62c/Share
Tweet Send to a Friend
Synageva Biopharma (NASDAQ: GEVA) reported Q4 EPS of ($0.62), $0.02 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
